NTLA
Intellia Therapeutics Inc
Price:  
12.89 
USD
Volume:  
5,625,364.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NTLA Stock Forecast & Price Target

NTLA Stock Price Forecast

The average stock forecast for Intellia Therapeutics Inc (NTLA) in the next 12 months is 27.26 USD. This price target corresponds to an upside of 102.05%. The range of stock forecasts for NTLA is 9.09 - 99.75 USD. Based on the ratings of 28 analysts, the consensus recommendation for NTLA is HOLD.
Target Low Average Median High
Price (USD) 9.09 27.26 17.85 99.75
Upside -32.62% 102.05% 32.32% 639.44%

Recommendation Trends

The latest consensus rating for NTLA is "HOLD". This is the average recommendation of 28 analysts: 0 strong sell, 2 sell, 11 hold, 10 buy, 5 strong buy. In the previous period, 30 analysts also majorly recommmended "BUY" for NTLA.

NTLA Financial Stock Forecast

Revenue This Year
61.12M
-9.68%
from 67.67M
Revenue Next Year
116.82M
91.14%
from 61.12M
EPS This Year
-3.27
10.87%
from -2.95
EPS Next Year
-2.80
-14.53%
from -3.27